Tacrolimus (FK506) reduces ischemia-induced hippocampal damage in rats: a 7- and 30-day study
AUTOR(ES)
Giordani, F., Benetolli, A., Favero-Filho, L.A., Lima, K.C.M., Cestari Junior, L., Milani, H.
FONTE
Brazilian Journal of Medical and Biological Research
DATA DE PUBLICAÇÃO
2003-04
RESUMO
The neuroprotective effect of the immunosuppressant agent FK506 was evaluated in rats after brain ischemia induced for 15 min in the 4-vessel occlusion model. In the first experimental series, single doses of 1.0, 3.0 or 6.0 mg FK506/kg were given intravenously (iv) immediately after ischemia. In the second series, FK506 (1.0 mg/kg) was given iv at the beginning of reperfusion, followed by doses applied intraperitoneally (ip) 6, 24, 48, and 72 h post-ischemia. The same protocol was used in the third series except that all 5 doses were given iv. Damage to the hippocampal field CA1 was assessed 7 or 30 days post-ischemia on three different stereotaxic planes along the septotemporal axis of the hippocampus. Ischemia caused marked neurodegeneration on all planes (P<0.001). FK506 failed to provide neuroprotection to CA1 both when applied iv as a single dose of 1.0, 3.0 or 6.0 mg/kg (experiment 1), and after five iv injections of 1.0 mg/kg (experiment 3). In contrast, the repeated administration of FK506 combining iv plus ip administration reduced CA1 cell death on all stereotaxic planes both 7 and 30 days post-ischemia (experiment 2; P<=0.01). Compared to vehicle alone, FK506 reduced rectal temperature in a dose-dependent manner (P<=0.05); however, this effect did not alter normothermia (37ºC). FK506 reduced ischemic brain damage, an effect sustained over time and apparently dependent on repeated doses and on delivery route. The present data extend previous findings on the rat 4-vessel occlusion model, further supporting the possible use of FK506 in the treatment of ischemic brain damage.
Documentos Relacionados
- Avaliação do potencial embriotóxico do Tacrolimus (Fk506) administrado a ratas Wistar
- Ischemia-induced brain damage is enhanced in human renin and angiotensinogen double-transgenic mice
- Blockade of calcium-permeable AMPA receptors protects hippocampal neurons against global ischemia-induced death
- Increased intrapancreatic trypsinogen activation in ischemia-induced experimental pancreatitis.
- Paraplegia increased cardiac NGF content, sympathetic tonus, and the susceptibility to ischemia-induced ventricular tachycardia in conscious rats